Method for inducing differentiation into adipocytes, compounds controlling such differentiation and method of screening for same
CA 2360684 A1 · Owner: Helix Research Institute · Inventors: Wakao, Rika; Wakao, Hiroshi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It has been found out that prolactin, which is one of the components of fetal bovine serum (FBS), is capable of inducing the expression of C/EBP.beta. gene and PPAR.gamma. gene in multipotential mesenchyme stem cells and thus differentiating these cells into adipocytes. It has been further found out that a compound regulating the differentiation into adipocytes can be screened by using an adipocyte differentiation system with the use of prolactin.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 2, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 2, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 2, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.